
When discussing African Swine Fever, many people immediately ask: “When will there be a vaccine strong enough to solve the problem?” WOAH’s February 2026 report suggests that the answer still needs to be approached with caution. The organization confirms that some countries have approved or are conducting field trials of live attenuated vaccine candidates against ASF genotype II. However, WOAH also emphasizes that only high-quality vaccines with proven safety and efficacy should be considered, and only in accordance with international standards in the Terrestrial Manual.
This is an extremely important message for the livestock sector. Vaccines may become part of the solution, but they are not a magic button that will eliminate ASF overnight. WOAH clearly states that any vaccination strategy must be embedded within a well-designed vaccination program, taking into account local epidemiology, circulating viral strains, expected outcomes, as well as technical, financial, and human resource capacity. In addition, such a program must include post-vaccination surveillance and even an exit strategy for when vaccination is no longer needed.

With this approach, it becomes clear that the future of pig health management will not rely on one single product, but on an integrated model combining vaccination, strict biosecurity, epidemiological monitoring, and continuous farmer training. For companies engaged in Veterinary Medicines Manufacture or Animals Medicines Manufacture, this is the right time to move beyond the role of being a simple producer and evolve into a provider of integrated solutions. Businesses that operate as Veterinary Medicines Exporter or Animals Medicines Exporter will have a stronger competitive advantage if they can support implementation, monitor outcomes, and provide technical guidance in the field.
The report also notes that at the time of WOAH’s review, no country or territory had officially reported large-scale vaccination as an active outbreak response or preventive measure. This detail shows that the international community is still acting cautiously, because ASF is a disease with major implications for trade, traceability, and market confidence. Therefore, for farmers and veterinary businesses, the most important priorities today remain controlling contact pathways, detecting abnormal signs early, and responding quickly to any sign of virus entry.
WOAH’s recommendations on page 7 stress that ASF remains a global threat and that the top priorities must be strict biosecurity, early reporting systems, rapid response capability, and maintaining a high level of awareness across the entire value chain. For the Veterinary Medicines Vietnam sector, this is a very clear direction for both SEO strategy and market development. Companies should talk more about disease prevention, risk control, farm management, and technical guidance, rather than focusing only on product performance in their communications.

From an international trade perspective, businesses in Veterinary Medicines Vietnam and Animals Medicines Vietnam that aim to expand globally need to understand that customers increasingly value brands with strong technical depth. An Animals Medicines Manufacture company is not only evaluated by its production capacity, but also by its ability to contribute to safer and more sustainable livestock development. At a time when the world is tightening disease control standards, companies that can combine product quality, technical consulting, and science-based communication will gain a meaningful long-term advantage.
In conclusion, the future of ASF control will not depend entirely on vaccines. It will depend on an integrated health management framework: the right vaccine when appropriate, strict biosecurity, post-vaccination monitoring, transparent epidemiology, and continuous farmer education. This is the moment for Animals Medicines Exporter, Veterinary Medicines Exporter, and manufacturers across the sector to reposition themselves as part of the long-term solution for safe and sustainable pig production worldwide.